AMICUS THERAPEUTICS INC (FOLD)

Overview Price 6.78 Price Change Today -$0.01 (-0.15%) P&P rating Zacks Rank 3 - HOLD Open Price $6.88 Previous Close $6.79 Daily Range $6.70 - $6.94 52-Week Range $2.10 - $8.12 Volume 256,141 AMICUS THERAPEUTICS is a biopharmaceutical company developing novel, oral therapeutics known as pharmacological chaperones for the treatment of a range of human genetic diseases. Pharmacological chaperone technology involves the use of small molecules that selectively bind to and stabilize proteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with unmet medical needs. Amicus has completed Phase 2 clinical trials of Amigal(TM) for the treatment of Fabry disease and is conducting Phase 2 clinical trials of Plicera(TM) for the treatment of Gaucher disease. Other Resources for FOLD Detailed Quote Earnings Estimates Company Report Interactive Chart Commentary No Commentary Found for This Ticker. AMICUS THERAPEUTICS is a biopharmaceutical company developing novel, oral therapeutics known as pharmacological chaperones for the treatment of a range of human genetic diseases. Pharmacological chaperone technology involves the use of small molecules that selectively bind to and stabilizeproteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with unmet medical needs. Amicus has completed Phase 2 clinical trials of Amigal(TM) for the treatment of Fabry disease and is conducting Phase 2 clinical trials of Plicera(TM) for the treatment of Gaucher disease.   Brokerage Analyst Recommendations 8 Brokerage Firms Covering FOLD   Strong Buy 4 Buy 0 Hold 4 Sell 0 Strong Sell 0 Average Broker Recommendation (ABR): 2   FOLD Ratings: BUY  SELL  HOLD FOLD Consensus Forecasts

Rate this Stock! You haven't rated this stock yet! Ticker Call Buy Sell Analysis Time Frame Week or Less Week to a Month One to Three Months Three to Six Months Six Months to a Year One to Three Years Three Plus Years What The Community Thinks Total Players 3 Buy 0 Sell   Top Buy Analysis No Buy Analysis. Be the First. More Recent Analysis Top Sell Analysis No Sell Analysis. Be the First. More Recent Analysis

Blog Posts

User	User Score	Date	Title	Comments	Last Comment
rjm77me	99.92	06/24/11	Notable insider buying / selling info for week:	0
zantriocom	0.00	10/05/09	Zantrio.com Free Daily Stock Picks 10-5-09	0
Zacks_Analysts	0.00	07/30/09	Earnings Preview: Amicus Therapeutics - Analyst Blog	0
Zacks_Analysts	0.00	07/06/09	Amicus Remains on Hold - Analyst Blog	0

Commentary

BUY: AMICUS THERAPEUTICS INC. (FOLD) Start Price: $2.77 Points: +138.01 Created: 11/14/2011 Comments: 0 | Comment sunlk8 Recs:

BUY: AMICUS THERAPEUTICS INC. (FOLD) Start Price: $14.51 Points: -60.32 Created: 07/19/2008 Comments: 0 | Comment MikeSmithTN Recs:

BUY: AMICUS THERAPEUTICS INC. (FOLD) Start Price: $15.69 Points: -48.65 Created: 01/01/2008 Comments: 0 | Comment Chinapolicy Recs:

Picks

Username	P&P Score	Call	Time Frame	Start Date	Start Price	Today (change)	Stock Gain	S&P Gain	Points	Analysis
sunlk8	99.76	BUY	Three to Six Months	11/14/2011	$2.77	$6.81 (-0.09%)	+145.99%	+7.98%	+138.01
MikeSmithTN	33.99	BUY	One to Three Months	07/19/2008	$14.51	$6.81 (-0.09%)	-53.04%	+7.28%	-60.32
Chinapolicy	27.56	BUY	Six Months to a Year	01/01/2008	$15.69	$6.81 (-0.09%)	-56.57%	-7.92%	-48.65